Obalon Therapeutics skyrocketed 568% on news it's merging with fellow weight-loss company ReShape Lifesciences. Trading volume of the stock soared to 370 million shares, higher than the stock's

Bitcoin Ethereum News. Aktier i Obalon Therapeutics Inc. OBLN, + 401.55% sprängdes fem gånger högre på massiv volym vid middagstid Bitcoin Crypto

Obalon Therapeutics' stock was trading at $1.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OBLN stock has increased by 170.2% and is now trading at $2.81. View which stocks have been most impacted by COVID-19. When did Obalon Therapeutics' stock split? The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger Obalon Therapeutics skyrocketed 568% on news it's merging with fellow weight-loss company ReShape Lifesciences.

Obalon therapeutics

US67424L2097, 24OA · Latest quotes · Issuer · IFRS/US GAAP reports · Other stocks and deposit receipts. 21 Jan 2021 Obalon Therapeutics skyrocketed 568% on news it's merging with fellow weight- loss company ReShape Lifesciences. Trading volume of the Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Stockopedia rates Obalon Therapeutics Inc as a Highly Speculative Momentum Trap . 1 brokers rate it as a 'Buy'. Click to view NAQ:OBLN's StockReport.

Klicka här för att följa aktiekursen i realtid 2021-01-20 · (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. OBLN is currently trading at $2 OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. 1 dag sedan · Obalon Therapeutics Inc. (OBLN) shares rose by 11.42% to trade at $3.22 in premarket at the time of writing. OBLN’s stock lost -2.36% on Friday’s session as it closed at $2.89.

obalon merger investigation: halper sadeh llp announces investigation into whether the merger of obalon therapeutics, inc. is fair to shareholders; investors are encouraged to contact the firm – obln. january 21, 2021.

Patients with prior weight loss surgeries are not eligible. The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible.

Obalon Therapeutics | 3 994 följare på LinkedIn. Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality

Obalon Therapeutics Overview · Website: www.obalon.com · Headquarters: Carlsbad, CA · Size: 51 to 200 Employees · Founded: null · Type: Company - Public ( 22 Feb 2021 Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and Obalon Therapeutics has 34 employees at their 1 location and $1.59 M in annual revenue in FY 2020.

Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Obalon Therapeutics är ett medicintekniskt bolag. Bolaget fokuserar på att utveckla och kommersialisera medicintekniska produkter för att behandla fetma och Köp aktier i Obalon Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Obalon Therapeutics | 3 994 följare på LinkedIn.
Helikopterpiloten idag

Shares of Obalon Therapeutics Inc. blasted six-fold higher on massive volume in afternoon trading Obalon Therapeutics Inc () Stock Market info Recommendations: Buy or sell Obalon Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Obalon Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Obalon Therapeutics's OBLN shares and potentially its market environment have been in a bullish cycle in Obalon Therapeutics, et al., No. 3:18-CV-0352-AJB-WVG, was filed in the Court on February 14, 2018. On July 24, 2018, the Court appointed Inter-Local as Lead Plaintiff.

2021-01-20 · Obalon Therapeutics and ReShape Lifesciences still need to complete customary closing conditions before the deal is complete. That includes getting approval from holders of OBLN stock and RSLS The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible.
Heta arbeten boden

2021-02-03

Earnings fell to a loss of $1.56 million, resulting in a 62.5% decrease from last quarter. 2021-01-20 · Obalon Therapeutics and ReShape Lifesciences still need to complete customary closing conditions before the deal is complete.

Obalon Therapeutics, som nyligen fick godkänt för Obalon, en produkt mot fetma studier och Sorrento Therapeutics efter det att bolaget ändrat affärsmodell.

5421 Avenida Encinas, Suite F Carlsbad, CA 92008-4410 USA Phone: 844-3OB-ALON (844-362-2566) For investor inquiries, please contact: Obalon Therapeutics, Inc. Investigation We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) in connection with the proposed merger of the Company with ReShape Lifesciences Inc. (“ReShape”) (OTCQB: RSLS). Obalon Therapeutics | 3 992 följare på LinkedIn. Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology.

2017-01-19 2020-11-27 Mr. Andrew P. Rasdal, also known as Andy, serves as Chief Executive Officer of Obalon Therapeutics, Inc. Mr. Rasdal has more than 25 years of medical technology experience. He served as Chief Executive Officer and President of DexCom, Inc., from January 2002 to June 2007. He served as Advisor of … 2020-12-07 2021-04-09 2021-04-10 Obalon Therapeutics, Inc. Investigation We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) in connection with the proposed merger of the Company with ReShape Lifesciences Inc. (“ReShape”) (OTCQB: RSLS). 2021-02-03 2021-04-07 2021-03-10 2020-06-06 2020-03-25 View the basic OBLN option chain and compare options of Obalon Therapeutics, Inc. on Yahoo Finance. 2021-03-10 2021-04-07 2020-12-07 The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program.